The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?
Open accessAbstract
The recent global pandemic of COVID-19 has predisposed a relatively high number of patients to acute respiratory distress syndrome (ARDS), which carries a risk of developing super-infections. Candida species are major constituents of the human mycobiome and the main cause of invasive fungal infections, with a high mortality rate. Invasive yeast infections (IYIs) are increasingly recognized as s complication of severe COVID-19. Despite the marked immune dysregulation in COVID-19, no prominent defects have been reported in immune cells that are critically required for immunity to Candida. This suggests that relevant clinical factors, including prolonged ICU stays, central venous catheters, and broad-spectrum antibiotic use, may be key factors causing COVID-19 patients to develop IYIs. Although data on the comparative performance of diagnostic tools are often lacking in COVID-19 patients, a combination of serological and molecular techniques may present a promising option for the identification of IYIs. Clinical awareness and screening are needed, as IYIs are difficult to diagnose, particularly in the setting of severe COVID-19. Echinocandins and azoles are the primary antifungal used to treat IYIs, yet the therapeutic failures exerted by multidrug-resistant Candida spp. such as C. auris and C. glabrata call for the development of new antifungal drugs with novel mechanisms of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Self-citationPappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045 · cited 1×
“One exception is the decreased expression of human leukocyte antigen DR on the membrane of circulating monocytes [36], which is considered a marker of immune paralysis; however, its relevance in susceptibility to candidemia is unclear.”
BackgroundSelf-citationFunctional exhaustion of antiviral lymphocytes in COVID-19 patients
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768 · cited 1×
“Similarly, an increased peripheral neutrophil-to-lymphocyte ratio was also observed in severe cases of COVID-19, and was likely associated with unfavorable prognosis [35].”
BackgroundPappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636
Kullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
Glowacka, I., Bertram, S., Müller, M. A., Allen, P., Soilleux, E., Pfefferle, S., Steffen, I., Tsegaye, T. S., He, Y., Gnirss, K., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02232-10 · Cited by 1,108
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
Mancia, G., Rea, F., Ludergnani, M., Apolone, G., & Corrao, G. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006923 · Cited by 1,073
Garcia-Vidal, C., Sanjuan, G., Moreno-García, E., Puerta-Alcalde, P., Garcia-Pouton, N., Chumbita, M., Fernandez-Pittol, M., Pitart, C., Inciarte, A., Bodro, M., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.041 · Cited by 1,022
Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Changes in the epidemiological landscape of invasive candidiasis
Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx444 · Cited by 547
-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
Fungi in the healthy human gastrointestinal tract
Hallen-Adams, H. E., & Suhr, M. J. (2017) · Virulence · doi:10.1080/21505594.2016.1247140 · Cited by 526
A Candida auris Outbreak and Its Control in an Intensive Care Setting
Eyre, D. W., Sheppard, A. E., Madder, H., Moir, I., Moroney, R., Quan, T. P., Griffiths, D., George, S., Butcher, L., Morgan, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714373 · Cited by 517
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019*
Auld, S. C., Caridi-Scheible, M., Blum, J. M., Robichaux, C., Kraft, C., Jacob, J. T., Jabaley, C. S., Carpenter, D., Kaplow, R., Hernandez-Romieu, A. C., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004457 · Cited by 510
Intestinal fungi contribute to development of alcoholic liver disease
Yang, A.-M., Inamine, T., Hochrath, K., Chen, P., Wang, L., Llorente, C., Bluemel, S., Hartmann, P., Xu, J., Koyama, Y., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90562 · Cited by 464
White, P. L., Dhillon, R., Cordey, A., Hughes, H., Faggian, F., Soni, S., Pandey, M., Whitaker, H., May, A., Morgan, M., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1298 · Cited by 445
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
Arastehfar, A., Carvalho, A., van de Veerdonk, F. L., Jenks, J. D., Koehler, P., Krause, R., Cornely, O. A., S. Perlin, D., Lass-Flörl, C., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6020091 · Cited by 421
Self-citationMarshall, R. P., Webb, S., Bellingan, G. J., Montgomery, H. E., Chaudhari, B., McAnulty, R. J., Humphries, S. E., Hill, M. R., & Laurent, G. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2108086 · Cited by 412
PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
Avni, T., Leibovici, L., & Paul, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01602-10 · Cited by 389
Chowdhary, A., Tarai, B., Singh, A., & Sharma, A. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2611.203504 · Cited by 330
Onishi, A., Sugiyama, D., Kogata, Y., Saegusa, J., Sugimoto, T., Kawano, S., Morinobu, A., Nishimura, K., & Kumagai, S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05267-11 · Cited by 328
Candida parapsilosis: from genes to the bedside
Tóth, R., Nosek, J., Mora-Montes, H. M., Gabaldon, T., Bliss, J. M., Nosanchuk, J. D., Turner, S. A., Butler, G., Vágvölgyi, C., & Gácser, A. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-18 · Cited by 327
Mikulska, M., Calandra, T., Sanguinetti, M., Poulain, D., Viscoli, C., & the Third European Conference on Infections in Leukemia Group (2010) · Critical Care · doi:10.1186/cc9365 · Cited by 319
The French Mycosis Study Group, Lortholary, O., Renaudat, C., Sitbon, K., Madec, Y., Denoeud-Ndam, L., Wolff, M., Fontanet, A., Bretagne, S., & Dromer, F. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3408-3 · Cited by 312
Diagnosing invasive candidiasis
Clancy, C. J., & Nguyen, M. H. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01909-17 · Cited by 293
Self-citationNguyen, M. H., Wissel, M. C., Shields, R. K., Salomoni, M. A., Hao, B., Press, E. G., Shields, R. M., Cheng, S., Mitsani, D., Vadnerkar, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis200 · Cited by 290
Self-citationChow, N. A., Gade, L., Tsay, S. V., Forsberg, K., Greenko, J. A., Southwick, K. L., Barrett, P. M., Kerins, J. L., Lockhart, S. R., Chiller, T. M., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30597-8 · Cited by 289
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
van de Veerdonk, F. L., Netea, M. G., van Deuren, M., van der Meer, J. W., de Mast, Q., Brüggemann, R. J., & van der Hoeven, H. (2020) · eLife · doi:10.7554/elife.57555 · Cited by 284
Self-citationMason, K. L., Erb Downward, J. R., Mason, K. D., Falkowski, N. R., Eaton, K. A., Kao, J. Y., Young, V. B., & Huffnagle, G. B. (2012) · Infection and Immunity · doi:10.1128/iai.00449-12 · Cited by 275
EL-EBIARY, M., TORRES, A., FÁBREGAS, N., de la BELLACASA, J. P., GONZÁLEZ, J., RAMIREZ, J., del BAÑO, D., HERNÁNDEZ, C., & JIMÉNEZ de ANTA, M. T. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.9612023 · Cited by 271
Azoulay, E., Timsit, J.-F., Tafflet, M., de Lassence, A., Darmon, M., Zahar, J.-R., Adrie, C., Garrouste-Orgeas, M., Cohen, Y., Mourvillier, B., et al. (2006) · Chest · doi:10.1378/chest.129.1.110 · Cited by 270
Marra, A. R., Camargo, L. F. A., Pignatari, A. C. C., Sukiennik, T., Behar, P. R. P., Medeiros, E. A. S., Ribeiro, J., Girão, E., Correa, L., Guerra, C., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00376-11 · Cited by 269
Meersseman, W., Lagrou, K., Spriet, I., Maertens, J., Verbeken, E., Peetermans, W. E., & Van Wijngaerden, E. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1482-8 · Cited by 231
Cornely, O. A., Hoenigl, M., Lass‐Flörl, C., Chen, S. C. ‐., Kontoyiannis, D. P., Morrissey, C. O., Thompson, G. R., & for the Mycoses Study Group Education and Research Consortium (MSG‐ERC) and the European Confederation of Medical Mycology (ECMM) (2019) · Mycoses · doi:10.1111/myc.12960 · Cited by 215
Self-citationFungal resistance to echinocandins and the MDR phenomenon in Candida glabrata
Healey, K., & Perlin, D. S. (2018) · doi:10.20944/preprints201808.0306.v1 · Cited by 194
Self-citationFungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
Healey, K. R., & Perlin, D. S. (2018) · Journal of Fungi · doi:10.3390/jof4030105 · Cited by 194
Self-citationTocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
Antinori, S., Bonazzetti, C., Gubertini, G., Capetti, A., Pagani, C., Morena, V., Rimoldi, S., Galimberti, L., Sarzi-Puttini, P., & Ridolfo, A. L. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102564 · Cited by 183
Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream Infection
Ben-Ami, R., Olshtain-Pops, K., Krieger, M., Oren, I., Bishara, J., Dan, M., Wiener-Well, Y., Weinberger, M., Zimhony, O., Chowers, M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05947-11 · Cited by 178
Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection
Bertolini, M., Ranjan, A., Thompson, A., Diaz, P. I., Sobue, T., Maas, K., & Dongari-Bagtzoglou, A. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007717 · Cited by 176
Lin, M., Carmeli, Y., Zumsteg, J. M., Flores, E., Tolentino, J., Sreeramoju, P., & Weber, S. G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4555-4560.2005 · Cited by 168
Clancy, C. J., Pappas, P. G., Vazquez, J., Judson, M. A., Kontoyiannis, D. P., Thompson, G. R., Garey, K. W., Reboli, A., Greenberg, R. N., Apewokin, S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1095 · Cited by 165
Self-citationSalehi, M., Ahmadikia, K., Mahmoudi, S., Kalantari, S., Jamalimoghadamsiahkali, S., Izadi, A., Kord, M., Dehghan Manshadi, S. A., Seifi, A., Ghiasvand, F., et al. (2020) · Mycoses · doi:10.1111/myc.13137 · Cited by 161
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S. (2020) · Journal of Fungi · doi:10.3390/jof6030138 · Cited by 145
Self-citationPrimary Candida pneumonia. Experience at a large cancer center and review of the literature.
Haron, E., Vartivarian, S. E., Anaissie, E. A., Dekmezian, R. H., & Bodey, G. P. (1993) · PubMed · Cited by 145
Primary Candida Pneumonia: Experience at a Large Cancer Center and Review of the Literature
Haron, E., Vartivarian, S., Anaissie, E., Dekmezian, R., & Bodey, G. P. (1993) · Medicine · doi:10.1097/00005792-199305000-00001 · Cited by 144
Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy
Calandra, T., Roberts, J. A., Antonelli, M. M., Bassetti, M., & Vincent, J. (2016) · Critical Care · doi:10.1186/s13054-016-1313-6 · Cited by 142
A National Strategy to Diagnose COVID-19 Associated Invasive Fungal Disease in the ICUPreprint
White, L. P., Dhillon, R., Cordey, A., Hughes, H. C., Faggian, F., Soni, S., Pandey, M. K., Whitaker, H., May, A., Morgan, M. P. G., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3644400 · Cited by 138
Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside
Aruanno, M., Glampedakis, E., & Lamoth, F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00399-19 · Cited by 136
Romo, J. A., & Kumamoto, C. A. (2020) · Journal of Fungi · doi:10.3390/jof6010016 · Cited by 124
Arastehfar, A. A., Daneshnia, F., Polat, S. H., Fang, W., Yaşar, M., Polat, F., Metin, D. Y., Rigole, P., Coenye, T., İlkit, M., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01001-20 · Cited by 119
Self-citationArastehfar, A. A., Daneshnia, F., Hafez, A. I., Khodavaisy, S., Najafzadeh, M. J., Charsizadeh, A., Zarrinfar, H., Salehi, M., Shahrabadi, Z. Z., Sasani, E., et al. (2019) · Medical Mycology · doi:10.1093/mmy/myz124 · Cited by 113
Self-citationPosteraro, B., Torelli, R., Vella, A., Leone, P. M., Angelis, G. D., Carolis, E. D., Ventura, G., Sanguinetti, M., & Fantoni, M. (2020) · Journal of Fungi · doi:10.3390/jof6030163 · Cited by 107
Zhao, Y., Prideaux, B., Nagasaki, Y., Lee, M. H., Chen, P.-Y., Blanc, L., Ho, H., Clancy, C. J., Nguyen, M. H., Dartois, V., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-17 · Cited by 102
Self-citationLeelahavanichkul, A., Worasilchai, N., Wannalerdsakun, S., Jutivorakool, K., Somparn, P., Issara-Amphorn, J., Tachaboon, S., Srisawat, N., Finkelman, M., & Chindamporn, A. (2016) · Shock · doi:10.1097/shk.0000000000000645 · Cited by 94
on behalf of ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva), Giacobbe, D. R., Mikulska, M., Tumbarello, M., Furfaro, E., Spadaro, M., Losito, A. R., Mesini, A., PASCALE, G. D., Marchese, A. E., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1763-5 · Cited by 94
COVID-19 associated invasive candidiasis
Al‐Hatmi, A. M. S., Mohsin, J., Huraizi, A. A., & Khamis, F. A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.08.005 · Cited by 94
Identification of Mycoses in Developing Countries
Arastehfar, A. A., Wickes, B. L., İlkit, M., Pincus, D., Daneshnia, F., Pan, W., Fang, W., & Boekhout, T. (2019) · Journal of Fungi · doi:10.3390/jof5040090 · Cited by 89
Self-citationThe lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic
Chowdhary, A., & Sharma, A. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.06.003 · Cited by 85
Ventoulis, I., Sarmourli, T., Amoiridou, P., Mantzana, P., Exindari, M., Gioula, G., & Vyzantiadis, T. (2020) · Journal of Fungi · doi:10.3390/jof6030098 · Cited by 84
Posteraro, B., Tumbarello, M., PASCALE, G. D., Liberto, E., Vallecoccia, M. S., Carolis, E. D., Gravio, V. D., Trecarichi, E. M., Sanguinetti, M., & Antonelli, M. M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw112 · Cited by 82
Fungal infections in adult patients on extracorporeal life support
Cavayas, Y. A., Yusuff, H. O., & Porter, R. (2018) · Critical Care · doi:10.1186/s13054-018-2023-z · Cited by 80
Arastehfar, A. A., Daneshnia, F., Najafzadeh, M. J., Hagen, F., Mahmoudi, S., Salehi, M., Zarrinfar, H., Namvar, Z., Zareshahrabadi, Z., Khodavaisy, S., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00206 · Cited by 75
Self-citationManagement of candidiasis in the intensive care unit
Schelenz, S. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm430 · Cited by 74
Issara-Amphorn, J., Surawut, S., Worasilchai, N., Thim-uam, A., Finkelman, M., Chindamporn, A., Palaga, T., Hirankarn, N., Pisitkun, P., & Leelahavanichkul, A. (2018) · Journal of Innate Immunity · doi:10.1159/000486321 · Cited by 69
Recommendations for the use of vascular access in the COVID-19 patients: an Italian perspective
on behalf of the GAVeCeLT Working Group for Vascular Access in COVID-19, Pittiruti, M., & Pinelli, F. (2020) · Critical Care · doi:10.1186/s13054-020-02997-1 · Cited by 67
Arastehfar, A. A., Daneshnia, F., Polat, S. H., İlkit, M., Yaşar, M., Polat, F., Metin, D. Y., Dökümcü, Z., Pan, W., Hagen, F., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa419 · Cited by 53
Self-citationCandida Pneumonia in Intensive Care Unit?
Schnabel, R. M., Linssen, C. F. M., Guion, N., van Mook, W., & Bergmans, D. C. J. J. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu026 · Cited by 48
Ko, J., Jung, D. S., Lee, J. Y., Kim, H. A., Ryu, S. Y., Jung, S., Joo, E., Cheon, S., Ys, K., Kim, S., et al. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.05.017 · Cited by 46
Minority report: the intestinal mycobiota in systemic infections
Rolling, T., Hohl, T. M., & Zhai, B. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.05.004 · Cited by 45
Prattes, J., Hoenigl, M., Rabensteiner, J., Raggam, R. B., Prüller, F., Zollner‐Schwetz, I., Valentin, T., Hönigl, K., Fruhwald, S. M., & Krause, R. (2014) · Mycoses · doi:10.1111/myc.12221 · Cited by 42
Self-citationPerformance of the T2Candida Panel for the Diagnosis of Intra-abdominal Candidiasis
Lamoth, F., Clancy, C. J., Tissot, F., Squires, K. M., Eggimann, P., Flückiger, U. M., Siegemund, M., Orasch, C., Zimmerli, S., Calandra, T., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa075 · Cited by 41
Self-citationArastehfar, A., Hilmioğlu-Polat, S., Daneshnia, F., Hafez, A., Salehi, M., Polat, F., Yaşar, M., Arslan, N., Hoşbul, T., Ünal, N., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.587278 · Cited by 40
Self-citationLeelahavanichkul, A., Panpetch, W., Worasilchai, N., Somparn, P., Chancharoenthana, W., Nilgate, S., Finkelman, M., Chindamporn, A., & Tumwasorn, S. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnw204 · Cited by 31
ECMM CandiReg—A ready to use platform for outbreaks and epidemiological studies
Koehler, P. A., Arendrup, M. C., Arıkan-Akdağlı, S., Bassetti, M., Bretagne, S., Klingspor, L., Lagrou, K., Meis, J. F. G. M., Rautemaa‐Richardson, R., Schelenz, S., et al. (2019) · Mycoses · doi:10.1111/myc.12963 · Cited by 29
Self-citationFungal Translocation: A Driving Force Behind the Occurrence of Non-AIDS Events?
Hoenigl, M. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz215 · Cited by 25
Self-citationGlucan rich nutrition does not increase gut translocation of beta‐glucan
Hoenigl, M., Lin, J. C.-Y., Finkelman, M., Zhang, Y., Karris, M., Letendre, S. L., Ellis, R. J., Burke, L., Richard, B., Gaufin, T., et al. (2020) · Mycoses · doi:10.1111/myc.13161 · Cited by 23
Self-citationT2Candida magnetic resonance in patients with invasive candidiasis: Strengths and limitations
Zurl, C., Prattes, J., Zollner‐Schwetz, I., Valentin, T., Rabensteiner, J., Wunsch, S., Hoenigl, M., & Krause, R. (2019) · Medical Mycology · doi:10.1093/mmy/myz101 · Cited by 22
Self-citation
Cited by
Tackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
COVID-19-associated fungal infections
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482
Self-citationThe emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Hoenigl, M., Seidel, D., Carvalho, A., Rudramurthy, S. M., Arastehfar, A., Gangneux, J.-P., Nasir, N., Bonifaz, A., Araiza, J., Klimko, N., et al. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00237-8 · Cited by 443
Self-citationGut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Zhang, F., Lau, R. I., Liu, Q., Su, Q., Chan, F. K. L., & Ng, S. C. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00698-4 · Cited by 267
The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic
Seagle, E. E., Jackson, B. R., Lockhart, S. R., Georgacopoulos, O., Nunnally, N. S., Roland, J., Barter, D. M., Johnston, H. L., Czaja, C. A., Kayalioglu, H., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab562 · Cited by 141
Metadata
- Authors
- Arastehfar, A., Carvalho, A., Nguyen, M. H., Hedayati, M. T., Netea, M. G., Perlin, D. S., & Hoenigl, M.
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2020-10-08
- Volume
- 6
- Issue
- 4
- Pages
- 211
- ISSN
- 2309-608X (ISSN-L)
- OpenAlex
- W3092528479
- Cited by
- 272
- References
- 86
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.